Hiroko Minatogawa

3PUBLICATIONS
1CO-AUTHORS
Corpus linguisticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 15, 2024
Reply to L. Celio et al.

Hiroko Minatogawa, Naoki Izawa, Takako Eguchi Nakajima

|Nov 17, 2023
Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial).

Hiroko Minatogawa, Naoki Izawa, Kazuhiro Shimomura

|Dec 18, 2020
Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1-4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy.

Hiroko Minatogawa, Naoki Izawa, Takashi Kawaguchi

Pageof 1

Frequent Collaborators

2 joint publications

Takako Eguchi Nakajima